اثربخشی درمان‌های بیومدیکال بر نشانه‌ها و رضایتمندی خانواده‌ها در اختلال طیف اوتیسم

Adams, J. B., Audhya, T., Geis, E., Gehn, E., Fimbres, V., Pollard, E. L., ... & Quig, D. W. (2018). Comprehensive nutritional and dietary intervention for autism spectrum disorder—A randomized, controlled 1‌2-month trial. Nutrients, 10(3), 369

 Aishworiya, R., Valica, T., Hagerman, R., & Restrepo, B. (2022). An update on psychopharmacological treatmen of autism spectrum disorder. Neurotherapeutics, 1-15.‏

 Botha, M., Dibb, B., & Frost, D. M. (2022). " Autism is me": an investigation of how autistic individuals make sense of autism and stigma. Disability & Society, 37(3), 427-453.

 Bragg, M., Chavarro, J.E., Hamra, G.B. et al. Prenatal Diet as a Modifier of Environmental Risk Factors for Autism and Related Neurodevelopmental Outcomes. Curr Envir Health Rpt 9, 324–338 (2022). https://doi.org/10.1007/s40572-022-00347-7

 Chaste, P., & Leboyer, M. (2022). Autism risk factors: genes, environment, and gene-environment interactions. Dialogues in clinical neuroscience.

 Cristiano, C., Volpicelli, F., Crispino, M., Lacivita, E., Russo, R., Leopoldo, M., ... & Perrone-Capano, C. (2022). Behavioral, Anti-Inflammatory, and Neuroprotective Effects of a Novel FPR2‌ Agonist in Two Mouse Models of Autism. Pharmaceuticals, 1‌5‌(2), 161.‏

 El-Ansary, A., Bjørklund, G., Khemakhem, A. M., Al-Ayadhi, L., Chirumbolo, S., & Ben Bacha, A. (2018). Metabolism-Associated Markers and Childhood Autism Rating Scales (CARS) as a Measure of Autism Severity. Journal of molecular neuroscience: MN, 65(3), 265–276. https://doi.org/10.1007/s12031-018-1091-5"

 El-Ansary, A., Cannell, J. J., Bjørklund, G., Bhat, R. S., Al Dbass, A. M., Alfawaz, H. A., Chirumbolo, S., & Al-Ayadhi, L. (2018). In the search for reliable biomarkers for the early diagnosis of autism spectrum disorder: the role of vitamin D. Metabolic brain disease, 3‌3‌(3), 917–931. https://doi.org/10.10‌0‌7‌/s1‌1‌0‌11-018-0‌1‌9‌9‌-1‌

 Esnafoglu, E., & Subaşı, B. (2022). Association of low 25-OH-vitamin D levels and peripheral inflammatory markers in patients with autism spectrum disorder: Vitamin D and inflammation in Autism. Psychiatry Research, 316, 114735.‏

 Freguia, C. F., Marriott, A., Gill, D., & Kaleko, M. (2020). Maternal treatment with oral intestinal alkaline phosphatase mitigates high fat diet-induced cognitive disorders in offspring mice. Behavioural Brain Research, 392, 112701.‏

 Herman, A., & Herman, A. P. (2022). Could Candida Overgrowth Be Involved in the Pathophysiology of Autism?. Journal of Clinical Medicine, 11(2), 442

 Hoekstra, R. A. (2022). Serving the underserved: How can we reach autism families who systemically miss out on support?. Autism, 26(6), 1315-1319.‏

 Höfer, J., Hoffmann, F., Dörks, M., Kamp-Becker, I., Küpper, C., Poustka, L., ... & Bachmann, C. J. (2022). Health Services Use and Costs in Individuals with Autism Spectrum Disorder in Germany: Results from a Survey in ASD Outpatient Clinics. Journal of autism and developmental disorders, 52(2), 540-552.‏

 Inoue, R., Sakaue, Y., Sawai, C., Sawai, T., Ozeki, M., Romero-Pérez, G. A., & Tsukahara, T. (2016). A preliminary investigation on the relationship between gut microbiota and gene expressions in peripheral mononuclear cells of infants with autism spectrum disorders. Bioscience, biotechnology, and biochemistry, 80(12), 2450-2458.‏

 Granero, R. (2022). Role of Nutrition and Diet on Healthy Mental State. Nutrients, 14(4), 750.‏

 Leadbitter, K., Smallman, R., James, K., Shields, G., Ellis, C., Langhorne, S., ... & Green, J. (2022). REACH-ASD: a UK randomised controlled trial of a new post-diagnostic psycho-education and acceptance and commitment therapy programme against treatment-as-usual for improving the mental health and adjustment of caregivers of children recently diagnosed with autism spectrum disorder. Trials, 23(1), 1-18.

 Lerner, M. D., White, S. W., & McPartland, J. C. (2022). Mechanisms of change in psychosocial interventions for autism spectrum disorders. Dialogues in clinical neuroscience.

 López-Muñoz, F. (2023). Commentary on The discovery of the butyrophenone-type neuroleptics by PAJ Janssen and JP Tollenaere. In Discoveries in Pharmacology (pp. 81-87). Academic Press

 Lugo-Marin, J., Magan-Maganto, M., Rivero-Santana, A., Cuellar-Pompa, L., Alviani, M., Jenaro-Rio, C., ... & Canal-Bedia, R. (2019). Prevalence of psychiatric disorders in adults with autism spectrum disorder: A systematic review and meta-analysis. Research in Autism Spectrum Disorders, 59, 22-33.

 Meguid, N. A., Mawgoud, Y. I. A., Bjørklund, G., Mehanne, N. S., Anwar, M., Effat, B. A. E. K., ... & Elrahman, M. M. A. (2022). Molecular Characterization of Probiotics and Their Influence on Children with Autism Spectrum Disorder. Molecular Neurobiology, 1-7. (2022): 297-304.‏

 Nadeem, A., Ahmad, S. F., Al-Harbi, N. O., Al-Ayadhi, L. Y., Sarawi, W., Attia, S. M., ... & AsSobeai, H. M. (2022). Imbalance in pro-inflammatory and anti-inflammatory cytokines milieu in B cells of children with autism. Molecular Immunology, 141, 297-304.‏

 Nyrenius, J., Eberhard, J., Ghaziuddin, M., Gillberg, C., & Billstedt, E. (2022). Prevalence of Autism Spectrum Disorders in Adult Outpatient Psychiatry. Journal of Autism and Developmental Disorders, 1-11.‏

 Ostadkarampour, M., & Putnins, E. E. (2021). Monoamine oxidase inhibitors: a review of their anti-inflammatory therapeutic potential and mechanisms of action. Frontiers in Pharmacology, 12, 676239.‏

 Pattison, E., Papadopoulos, N., Marks, D., McGillivray, J., & Rinehart, N. (2020). Behavioural treatments for sleep problems in children with autism spectrum disorder: A review of the recent literature. Current psychiatry reports, 22(9), 1-10.

 Pretzsch, C.M.; Voinescu, B.; Lythgoe, D.; Horder, J.; Mendez, M.A.; Wichers, R.; Ajram, L.; Ivin, G.; Heasman, M.; Edden, R.A.E.; et al. Effects of Cannabidivarin (CBDV) on Brain Excitation and Inhibition Systems in Adults with and without Autism Spectrum Disorder (ASD): A Single Dose Trial During Magnetic Resonance Spectroscopy. Transl. Psychiatry 2019, 9, 313. [Google Scholar] [CrossRef] [PubMed][Green Version]

 Qasem, H., Al-Ayadhi, L., Bjørklund, G., Chirumbolo, S., & El-Ansary, A. (2018). Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder. Metabolic brain disease, 33(4), 1141–1153. https://doi.org/10.1007/s11011-018-0206-6

 Schiavi, S., Carbone, E., Melancia, F., Buzzelli, V., Manduca, A., Campolongo, P., ... & Trezza, V. (2022). Perinatal supplementation with omega-3 fatty acids corrects the aberrant social and cognitive traits observed in a genetic model of autism based on FMR1 deletion in rats. Nutritional Neuroscience, 25(5), 898-911.

 Siafis, S., Çıray, O., Wu, H., Schneider-Thoma, J., Bighelli, I., Krause, M., ... & Leucht, S. (2022). Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Molecular autism, 13(1), 1-17.

 Volkmar, F. R., Reichow, B., & McPartland, J. (2022). Classification of autism and related conditions: progress, challenges, and opportunities. Dialogues in clinical neuroscience.

 Williams, L. A., & LaSalle, J. M. (2022). Future Prospects for Epigenetics in Autism Spectrum Disorder. Molecular diagnosis & therapy, 10.1007/s40291-022-00608-z. Advance online publication. https://doi.org/10.1007/s40291-022-00608z